RxDoctor Payments Data

Beki Garrett, PA

Physician Assistant · Omaha, NENPI 1629231808

Payments from drug & device makers

$1,727in general payments, 2019–2025

Across 79 payments — averaging $21.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$561
  • Optinose US, Inc.$472
  • Sanofi$159
  • Kaleo, Inc.$113
  • GSK$81
  • Amgen$71
  • plus $270 from 7 others

What the payments were for

  • Food & beverage$1,67097%
  • Education$583%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,727 in reported general payments places this provider in the 80th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska

Medicare billing

Part B allowed, 2024
$65,271
Medicare patients
385
Services billed
1,157

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Epinephrine22$2,884
Ipratropium Bromide123$2,851
Azelastine Hcl81$2,759
Fluticasone Propionate176$2,577
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth20$2,529
Omeprazole95$1,226
Azelastine-FluticasoneAzelastine/Fluticasone11$1,053
Ofloxacin18$681
Dexamethasone Sodium Phosphate13$516
Pantoprazole Sodium45$500
Montelukast Sodium88$495
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav50$474
Levocetirizine Dihydrochloride30$432
Doxycycline Hyclate30$356
Methylprednisolone39$302

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Hikma Pharmaceuticals USAEpinephrine$17$2,88422 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,127 physician assistant providers in Nebraska.

Other physician assistant in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →